文献速递重症综合管理与镇静镇痛

比较临床衰弱量表与ICD-10改良衰弱指数对危重患者长期生存的预测价值

Comparing the Clinical Frailty Scale and an International Classification of Diseases-10 Modified Frailty Index in Predicting Long-Term Survival in Critically Ill Patients.
PubMed 文献 · Crit Care Explor · 2022-10-13
一句话结论在澳大利亚16个ICU的7001例成人患者中,临床衰弱量表(CFS)可预测6个月生存,而ICD-10改良衰弱指数(ICD-10mFI)不能,两者不等价,当前形式的ICD-10mFI不应使用。

本研究为回顾性多中心观察性研究,纳入2017年4月1日至2018年6月30日澳大利亚维多利亚州16个ICU收治的、有CFS记录的成人(≥16岁)危重患者,通过概率匹配链接数据库,比较CFS与ICD-10mFI对ICU入院后最长可达1年生存的预测能力。共分析7001例患者,CFS判定的衰弱比例高于ICD-10mFI(18.9% [n=1323] vs 8.8% [n=616];p<0.001)。校正混杂因素后,CFS可预测6个月生存(HR=1.26,95%CI 1.21-1.31),而ICD-10mFI不能(HR=1.04,95%CI 0.98-1.10)。ICD-10mFI与CFS相关性弱(Spearman's rho=0.22)且一致性差(kappa=0.06),与Charlson合并症指数的相关性(rho=0.30)强于CFS(rho=0.25)(p<0.001)。作者认为两者不等价,当前形式的ICD-10mFI不应使用。

要点

  • 在7001例ICU患者中,CFS判定的衰弱比例高于ICD-10mFI(18.9% [n=1323] vs 8.8% [n=616];p<0.001)。
  • 校正混杂因素后,CFS可预测6个月生存(HR=1.26,95%CI 1.21-1.31),而ICD-10mFI不能(HR=1.04,95%CI 0.98-1.10)。
  • ICD-10mFI与CFS相关性弱(Spearman's rho=0.22)且一致性差(kappa=0.06)。
  • ICD-10mFI与Charlson合并症指数的相关性(Spearman's rho=0.30)强于CFS(rho=0.25)(p<0.001),提示其更多反映合并症而非衰弱。
  • 作者认为CFS与ICD-10mFI不等价,当前形式的ICD-10mFI不应使用。

适用人群与场景

  • 2017年4月1日至2018年6月30日澳大利亚维多利亚州16个ICU收治的成人(≥16岁)危重患者,且记录有CFS评分。

研究设计与关键结果

  • 研究类型:回顾性多中心观察性研究;样本量7001例ICU患者;16个澳大利亚ICU;随访时间中位数(IQR)165(82-276)天。
  • 衰弱比例:CFS判定为衰弱者18.9%(n=1323),ICD-10mFI判定为衰弱者8.8%(n=616),p<0.001。
  • 主要终点(校正混杂因素后预测最长可达1年生存):CFS可预测6个月生存(HR=1.26,95%CI 1.21-1.31);ICD-10mFI不能预测(HR=1.04,95%CI 0.98-1.10)。
  • ICD-10mFI与CFS相关性弱(Spearman's rho=0.22),一致性差(kappa=0.06)。
  • ICD-10mFI与Charlson合并症指数的相关性(Spearman's rho=0.30)强于CFS(rho=0.25),p<0.001。

证据类型、等级与局限

  • 证据类型:回顾性多中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CFS与ICD-10mFI在危重患者衰弱筛查中不等价,当前形式的ICD-10mFI不应使用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: The Clinical Frailty Scale (CFS) is the most used frailty measure in intensive care unit (ICU) patients. Recently, the modified frailty index (mFI), derived from 11 comorbidities has also been used. It is unclear to what degree the mFI is a true measure of frailty rather than comorbidity. Furthermore, the mFI cannot be freely obtained outside of specific proprietary databases.

OBJECTIVE: To compare the performance of CFS and a recently developed International Classification of Diseases-10 (ICD-10) mFI (ICD-10mFI) as frailty-based predictors of long-term survival for up to 1 year.

DESIGN: A retrospective multicentric observational study.

SETTING AND PARTICIPANTS: All adult (≥16 yr) critically ill patients with documented CFS scores admitted to sixteen Australian ICUs in the state of Victoria between April 1, 2017 to June 30, 2018 were included. We used probabilistic methods to match de-identified ICU admission episodes listed in the Australia and New Zealand Intensive Care Society Adult Patient Database with the Victorian Admission Episode Dataset and the Victorian Death Index via the Victorian Data Linkage Centre.

MAIN OUTCOMES AND MEASURES: The primary outcome was the longest available survival following ICU admission. We compared CFS and ICD-10mFI as primary outcome predictors, after adjusting for key confounders.

RESULTS: The CFS and ICD-10mFI were compared in 7,001 ICU patients. The proportion of patients categorized as frail was greater with the CFS than with the ICD-10mFI (18.9% [n = 1,323] vs. 8.8% [n = 616]; p < 0.001). The median (IQR) follow-up time was 165 (82-276) days. The CFS predicted long-term survival up to 6 months after adjusting for confounders (hazard ratio [HR] = 1.26, 95% CI, 1.21-1.31), whereas ICD-10mFI did not (HR = 1.04, 95% CI, 0.98-1.10). The ICD-10mFI weakly correlated with the CFS (Spearman's rho = 0.22) but had a poor agreement (kappa = 0.06). The ICD-10mFI more strongly correlated with the Charlson comorbidity index (Spearman's rho 0.30) than CFS (Spearman's rho = 0.25) (p < 0.001).

CONCLUSIONS: CFS, but not ICD-10mFI, predicted long-term survival in ICU patients. ICD-10mFI correlated with co-morbidities more than CFS. These findings suggest that CFS and ICD-10mFI are not equivalent.

RELEVANCE: CFS and ICD-10mFI are not equivalent in screening for frailty in critically ill patients and therefore ICD-10mFI in its current form should not be used.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Subramaniam A, Ueno R, Tiruvoipati R, et al. Comparing the Clinical Frailty Scale and an International Classification of Diseases-10 Modified Frailty Index in Predicting Long-Term Survival in Critically Ill Patients. Crit Care Explor. 2022. PMID: 36259062. doi:10.1097/CCE.0000000000000777

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。